A Study of PN20 in Healthy Adult Volunteers

Summary

The main aim of this clinical trial is to assess the safety of PN20 in healthy volunteers aged 18 to 50 years. The main questions it aims to answer are: * Is PN20 safe in adult? Researchers will compare PN20 to a placebo (a look-alike substance that contains no drug) to see if PN20 is safe. Participants will * Receive a single dose injection of PN20 or placebo according to weight, * Stay in hospital for assessment.

Timeline

Start

2022-06-16

Primary completion

2023-01-05

Completion

2023-01-05

Drugs

Indications